Insightec

Electromedical equipment

InSightec developed ExAblate using MR guided focused ultrasound. Approved for commercial treatment in many countries ExAblate treats bone tumors uterine fibroids in a non-invasive outpatient way.

Insightec, developer of ExAblate OR, ExAblate ONE, MRI guided Focused Ultrasound Surgery, or MRgFUS, treats uterine fibroids non-invasively in an out patient setting without the need for general anesthesia or hospitalization, greatly reducing recovery time and the risks of side effects.